Novel macrocyclic inhibitors of hepatitis c virus replication

作者: Scott D. Seiwert , Timothy Kercher , Tarek Sammakia , Bradley R. Barnett , Paul Nichols

DOI:

关键词: Liver fibrosisBiologyHepatitis C virusVirologyTreatment methodPharmacology

摘要: The embodiments provide compounds of the general Formulae (I) through Formula (VIII), as well compositions, including pharmaceutical comprising a subject compound. further treatment methods, methods treating hepatitis C virus infection and liver fibrosis, generally involving administering to an individual in need thereof effective amount compound or composition.

参考文章(165)
Clifford A. Brass, Janice K. Albrecht, Methods of treating hepatitis C virus ,(2006)
Raymond G. Lovey, Jinping McCormick, Ashit K. Ganguly, Anil K. Saksena, Viyyoor M. Girijavallabhan, Frank Bennett, 5′-amino acid esters of ribavirin and the use of same to treat hepatitis C with interferon ,(1999)
Constantine G. Boojamra, Aesop Cho, William J. Watkins, Anti-infective phosphonate analogs ,(2004)
Chu-Chung Lin, Pei-Chin Cheng, Yo-chin Liu, Chen-fu Liu, Chi-Hsin Richard King, None, Hcv protease inhibitors ,(2008)
Philip Stephen Jones, David Nigel Hurst, Tony Michael Raynham, Paul Brittain Kay, Michael Richard Attwood, Francis Xavier Wilson, Peptidyl inhibitors of viral proteases ,(1997)
Robert B. Perni, Luc J. Farmer, John van Drie, Lawrence F. Courtney, Janos Pitlik, Bridged bicyclic serine protease inhibitors ,(2002)
Howard C. Ansel, Loyd V. Allen, Nicholas G. Popovich, Pharmaceutical Dosage Forms and Drug Delivery Systems ,(1997)